Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: EH....may I suggest reading the following on listing requirements

Sorry, but I don't know, what you are after:

We reached 2$ in March 06 without any problems, with just three licensees in the pockets - why should we have a problem to get over 4,- or 5,- $ in the next four to five months, assuming we get a favorable settlement, 10 - 15 licensees per month and some great revenue-sources (companies purchased by Turley & Co from the settlement money)???

And what is 400mio shares in relation to 50-100 mio profit, which Patriot can/will make AT LEAST?

400mio shares at 5$ = 2billion market cap = PE 20-40 with 50-100mio profit and an exciting outlook for the next years...you really think, 400mio shares is too much?

Nothing speaks for a RS and besides: why discuss this topic now, I guess, there are much more important things to do for Patriot in the next days and weeks.

GLTA 

Share
New Message
Please login to post a reply